Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Insight Lifetech

Explore full profile

Transforming healthcare through innovation and quality, and with a vision to become a world-class medical technology company of long-lasting impact in innovative precision cardiovascular intervention

Shenzhen, ChinaFounded 2015Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2026
Revenue $50–100M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Insight Lifetech and the history behind them.

About Insight Lifetech

Insight Med is a medtech startup that operates in the healthcare industry, specifically focusing on cardiovascular diseases. The company is committed to developing innovative solutions that can transform the precision diagnosis and treatment of these diseases. Their clients are primarily healthcare providers who deal with cardiovascular diseases, including hospitals, clinics, and medical professionals.

The company operates in a market that is constantly evolving and growing due to the increasing prevalence of cardiovascular diseases globally. They are at the forefront of medical technology, developing products such as the Insight Lifetech PCI solution and the TRUEVISION and VivoHeart IVUS systems. These products have received approval from the National Medical Products Administration (NMPA), which is the Chinese authority responsible for regulating drugs and medical devices.

Insight Med's business model revolves around the development, production, and sale of these innovative medical technologies. They generate revenue through the sale of their products to healthcare providers. The company also participates in scientific symposiums and conferences, such as EuroPCR2023, to showcase their products and innovations, further driving their market presence and potential sales.

In summary, Insight Med is a pioneering medtech company that is making significant strides in the diagnosis and treatment of cardiovascular diseases through their innovative products.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Shenzhen, China
Employees
45
Open positions
None listed
Dealroom signal
88.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Cardiology and cardiovascular, Medical Imaging, Health Diagnostics, Hard Tech, Woman Founder, DT and LS, science-based
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Feb 2026 $137M $1B Undisclosed ↗
SERIES DOther financing Sep 2022 — $578M Qingzhi Capital · Taiping Medical and Health Fund · Zhou Jitongli · Taiping Medical ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Insight Lifetech website traffic

Latest recorded traffic for Insight Lifetech is 2.2K monthly website visits, up 161.9% over the last three months. Insight Lifetech's team grew 15.4% over the past year.

Latest monthly visits2.2K 3-month web change+161.9% 1-year team growth+15.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • China Gaoxin Investment Group Corp
  • Green Pine Capital
  • State Development & Investment Corporation (SDIC)
  • HSG
  • Hetang Venture Capital Management (Beijing)
  • Efung Capital
  • Sherpa Venture Partners

Series B and later8 investors entered at this stage

Other known investors1 additional known investor

  • Octagon Capital Advisors
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇨🇳 China82.9%
🇳🇱 Netherlands2.9%
🇮🇹 Italy2.9%
🇲🇾 Malaysia2.9%
🇭🇰 Hong Kong2.9%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Insight Lifetech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Insight Lifetech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.